A convergence of pharmaceutical scientists, systems architects, financial strategists, and communication specialists united by a single imperative: validate before you synthesize.
Jordan Schleicher directs the end-to-end R&D of NeurAeon's next-generation neural enhancement candidates. He is the primary architect behind the implementation of the NRRE-4 system, engineered to eliminate traditional R&D bottlenecks through laboratory precision and global scalability.
A KU Information Systems graduate with a background in Applied Science, Brennan specializes in turning complex technical requirements into user-ready platforms. His portfolio includes custom software, responsive websites, and intelligent chatbots for high-impact digital ecosystems.
With a Master's in Finance and over a decade of experience across investment, commercial, and central banking, Kir leads financial strategy and fundraising. He specializes in capital markets and corporate finance, aligning company growth with long-term investor value.
Matthew manages community outreach and communication for NeurAeon. His focus is on ensuring the company's mission and complex neurotechnological developments remain clear, accessible, and transparent to the public.
We are always seeking exceptional talent in computational biology, prompt engineering, and pharmaceutical sciences.